Group of people one male one female one male the rest not focused, walking down the street with masks on
TB Management

TB Risk Groups

Who is at risk for TB?

Anyone can be infected with tuberculosis. However, some people are at greater risk for TB than others.

The CDC has identified key groups who face an increased risk for TB infection and disease progression (1). For example, TB incidence is 18 times higher among non-US-born persons compared with those born in the US (2).

Other groups at increased risk for TB include people living with HIV or experiencing immunosuppression, contacts of active TB cases, healthcare workers and children.

Who is at risk for TB - infographic
TB in the United States

Up to 13 million people in the US are believed to carry TB infection (3). More than 9,000 cases of infectious active TB are reported each year (2).

According to the CDC, the elimination of TB in the US requires timely testing and expanded treatment options.

TB case detection in the US was set back by testing delays during the COVID-19 pandemic. Although case detection has recovered, concerns persist about missed TB diagnoses and the ongoing effects of pandemic-related disruptions to public health (2).

Are you offering single-visit TB testing for your community?

Primary care providers, community health centers and urgent cares all provide front-line testing and employment screening for their communities. These sites play a critical role in TB prevention in the US.

Did you know that proactive TB screening is recommended for patients at increased risk (4)?

Offering a single-visit TB blood testing with QuantiFERON-TB Gold Plus (QFT-Plus) lets you streamline testing and helps protect your at-risk patients.
Adopt an accurate and convenient latent TB test
Get in touch with us to find out more about latent TB testing solutions.
Contact us

Learn more about TB in the US

QuantiFERON-TB Gold Plus tubes
Improve TB screening with QFT-Plus
  • Single patient visit
  • Unaffected by BCG vaccination
  • >94% sensitivity
  • >97% specificity
  • Innovative CD8+ T cell technology
Learn more

Contact us

References:
  1. US CDC. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis Infection — United States, 2010. MMWR59 RR-5
  2. US CDC. Tuberculosis — United States, 2023. https://www.cdc.gov/mmwr/volumes/73/wr/mm7312a4.htm
  3. US CDC. Tuberculosis – data and statistics. https://www.cdc.gov/tb/statistics/default.htm
  4. US Preventive Services Task Force. Screening for latent tuberculosis infection in adults. JAMA. 2016;316:962–969
  5. Lewinsohn DM, et al. Official ATS/IDSA/CDC clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–115.

QFT -Plus is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations.